AWA
SRNE

Acorn Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Acorn Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,194
Closed -$29K – 172
2022
Q4 		$29K Buy
33,194
+410
+1% +$544 0.02% 158
2022
Q3 		$51K Buy
32,784
+574
+2% +$1.3K 0.04% 154
2022
Q2 		$65K Buy
32,210
+8,192
+34% +$14.2K 0.05% 160
2022
Q1 		$56K Buy
24,018
+8,704
+57% +$27.1K 0.04% 172
2021
Q4 		$71K Buy
15,314
+1,076
+8% +$6.68K 0.05% 179
2021
Q3 		$109K Buy
14,238
+3,948
+38% +$33.5K 0.08% 171
2021
Q2 		$100K Buy
+10,290
New +$81.9K 0.07% 166

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Acorn Wealth Advisors's SRNE Position: Q1 2023 in Review

Acorn Wealth Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 33,194 shares — an estimated $29K sold.

Acorn Wealth Advisors first reported a position in SRNE in Q2 2021 and held it in 7 quarters. The position peaked at $109K in Q3 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Acorn Wealth Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Acorn Wealth Advisors sold 33,194 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $29K.
  • Acorn Wealth Advisors first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 7 quarters.
  • Acorn Wealth Advisors's Sorrento Therapeutics, Inc. position peaked at $109K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Acorn Wealth Advisors's 13F filing for Q1 2023, filed 9 May 2023.